These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 24954768)

  • 1. Validation of the G8 screening tool in older patients with aggressive haematological malignancies.
    Velghe A; Petrovic M; De Buyser S; Demuynck R; Noens L
    Eur J Oncol Nurs; 2014 Dec; 18(6):645-8. PubMed ID: 24954768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition.
    Dubruille S; Libert Y; Roos M; Vandenbossche S; Collard A; Meuleman N; Maerevoet M; Etienne AM; Reynaert C; Razavi D; Bron D
    J Geriatr Oncol; 2015 Sep; 6(5):362-9. PubMed ID: 26277114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy.
    Hamaker ME; Mitrovic M; Stauder R
    Ann Hematol; 2014 Jun; 93(6):1031-40. PubMed ID: 24488257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive ability of the G8 screening test to determine probable sarcopenia and abnormal comprehensive geriatric assessment in older patients with solid malignancies.
    Cavusoglu C; Tahtaci G; Dogrul RT; Ileri I; Yildirim F; Candemir B; Kizilarslanoglu MC; Uner A; Goker B
    BMC Geriatr; 2021 Oct; 21(1):574. PubMed ID: 34666690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Groningen Frailty Indicator and the G8 questionnaire as screening tools for frailty in older patients with cancer.
    Baitar A; Van Fraeyenhove F; Vandebroek A; De Droogh E; Galdermans D; Mebis J; Schrijvers D
    J Geriatr Oncol; 2013 Jan; 4(1):32-8. PubMed ID: 24071490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hand grip strength as a screening tool for frailty in older patients with haematological malignancies.
    Velghe A; De Buyser S; Noens L; Demuynck R; Petrovic M
    Acta Clin Belg; 2016 Aug; 71(4):227-30. PubMed ID: 27118256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of G8 scale in referring elderly patients with aortic stenosis requiring a TAVI for a geriatric consultation.
    de Thézy A; Lafargue A; d'Arailh L; Dijos M; Leroux L; Salles N; Rainfray M
    Geriatr Psychol Neuropsychiatr Vieil; 2017 Dec; 15(4):357-363. PubMed ID: 29187325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of the G-8 geriatric-oncology screening tool for identifying vulnerable elderly patients with cancer according to tumour site: the ELCAPA-02 study.
    Liuu E; Canouï-Poitrine F; Tournigand C; Laurent M; Caillet P; Le Thuaut A; Vincent H; Culine S; Audureau E; Bastuji-Garin S; Paillaud E;
    J Geriatr Oncol; 2014 Jan; 5(1):11-9. PubMed ID: 24484713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cancer treatment in elderly patients: evidence and clinical research].
    Repetto L; Luciani A
    Recenti Prog Med; 2015 Jan; 106(1):23-7. PubMed ID: 25621776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity and reliability of the G8 screening test in older non-cancer patients.
    Cavusoglu C; Deniz O; Tuna Dogrul R; Ileri I; Yildirim F; Caliskan H; Ozsurekci C; Coteli S; Kizilarslanoglu MC; Goker B
    Eur Geriatr Med; 2021 Apr; 12(2):397-404. PubMed ID: 33000425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of geriatric assessment on the management of older adults with head and neck cancer: A pilot study.
    Neve M; Jameson MB; Govender S; Hartopeanu C
    J Geriatr Oncol; 2016 Nov; 7(6):457-462. PubMed ID: 27313080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the G8 Screening Tool for Older Patients With Cancer: Diagnostic Performance and Validation of a Six-Item Version.
    Martinez-Tapia C; Canoui-Poitrine F; Bastuji-Garin S; Soubeyran P; Mathoulin-Pelissier S; Tournigand C; Paillaud E; Laurent M; Audureau E;
    Oncologist; 2016 Feb; 21(2):188-95. PubMed ID: 26764250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Freund Clock Drawing Test as a screening tool to detect cognitive dysfunction in elderly cancer patients undergoing comprehensive geriatric assessment.
    Lycke M; Ketelaars L; Boterberg T; Pottel L; Pottel H; Vergauwe P; Goethals L; Van Eygen K; Werbrouck P; Debruyne D; Derijcke S; Borms M; Ghekiere V; Wildiers H; Debruyne PR
    Psychooncology; 2014 Oct; 23(10):1172-7. PubMed ID: 24729471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comprehensive geriatric assessment (CGA) in elderly with cancer: For whom?].
    Liuu E; Caillet P; Curé H; Anfasi N; De Decker L; Pamoukdjian F; Canouï-Poitrine F; Soubeyran P; Paillaud E;
    Rev Med Interne; 2016 Jul; 37(7):480-8. PubMed ID: 26997159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geriatric oncology screening tools for CGA-based interventions: results from a phase II study of geriatric assessment and management for older adults with cancer.
    Yokom DW; Alibhai SMH; Sattar S; Krzyzanowska MK; Puts MTE
    J Geriatr Oncol; 2018 Nov; 9(6):683-686. PubMed ID: 29540293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the G8 screening tool in older patients with cancer considered for surgical treatment.
    Bruijnen CP; Heijmer A; van Harten-Krouwel DG; van den Bos F; de Bree R; Witteveen PO; Emmelot-Vonk MH
    J Geriatr Oncol; 2021 Jun; 12(5):793-798. PubMed ID: 33172806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.
    Soubeyran P; Bellera C; Goyard J; Heitz D; Curé H; Rousselot H; Albrand G; Servent V; Jean OS; van Praagh I; Kurtz JE; Périn S; Verhaeghe JL; Terret C; Desauw C; Girre V; Mertens C; Mathoulin-Pélissier S; Rainfray M
    PLoS One; 2014; 9(12):e115060. PubMed ID: 25503576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of a self-administered G8 screening test for older patients with cancer.
    Chon J; Timilshina N; AlMugbel F; Jin R; Monginot S; Tejero I; Breunis H; Alibhai SMH
    J Geriatr Oncol; 2023 Sep; 14(7):101553. PubMed ID: 37379768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The performance of three oncogeriatric screening tools - G8, optimised G8 and CARG - in predicting chemotherapy-related toxicity in older patients with cancer. A prospective clinical study.
    Kotzerke D; Moritz F; Mantovani L; Hambsch P; Hering K; Kuhnt T; Yahiaoui-Doktor M; Forstmeyer D; Lordick F; Knödler M
    J Geriatr Oncol; 2019 Nov; 10(6):937-943. PubMed ID: 31085136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy.
    Baitar A; Van Fraeyenhove F; Vandebroek A; De Droogh E; Galdermans D; Mebis J; Schrijvers D
    J Geriatr Oncol; 2014 Apr; 5(2):179-84. PubMed ID: 24495700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.